NCT06981949View on ClinicalTrials.gov

Addition of Dexmedetomidine to Ropivacaine in Bilateral Erector Spinae Plane Block in Patients Undergoing Coronary Artery Bypass Surgery

PHASE4Not yet recruitingINTERVENTIONAL
Enrollment

110

Participants

Timeline

Start Date

May 15, 2025

Primary Completion Date

May 15, 2026

Study Completion Date

May 16, 2026

Conditions
PainPain Management Following Cardiopulmonary Bypass SurgeryErector Spinae Plane Block
Interventions
DRUG

Dexmedetomidine

"Dexmedetomidine added to ropivacaine in the bilateral single-shot Ultrasound-guided erector spinae plane block that will be applied to each side (bilateral):~20ml/side of 0.375% ropivacaine+0.5 μg/kg/side of dexmedetomidine (lean body weight if BMI \>30)"

DRUG

Ropivacaine

"Ropivacaine only in the Bilateral single-shot Ultrasound-guided Erector Spinae Plane Block:~20ml/side of 0.375% ropivacaine"

All Listed Sponsors
lead

Lebanese American University

OTHER